Mark Jesky

957 total citations
23 papers, 603 citations indexed

About

Mark Jesky is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Mark Jesky has authored 23 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Mark Jesky's work include Chronic Kidney Disease and Diabetes (10 papers), Renal Diseases and Glomerulopathies (4 papers) and Blood Pressure and Hypertension Studies (3 papers). Mark Jesky is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Renal Diseases and Glomerulopathies (4 papers) and Blood Pressure and Hypertension Studies (3 papers). Mark Jesky collaborates with scholars based in United Kingdom, Denmark and New Zealand. Mark Jesky's co-authors include Paul Cockwell, Charles J. Ferro, Anthony Fenton, Stephanie Stringer, M.A. Karsdal, Federica Genovese, Khai Ping Ng, Mary Ann Dutton, Daniel Guldager Kring Rasmussen and Punit Yadav and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Mark Jesky

23 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Jesky United Kingdom 16 221 178 97 76 70 23 603
Shikha Wadhwani United States 6 262 1.2× 79 0.4× 40 0.4× 66 0.9× 55 0.8× 13 522
Umut Selda Bayrakçı Türkiye 13 189 0.9× 74 0.4× 81 0.8× 40 0.5× 34 0.5× 59 510
Xiaojiang Zhan China 15 232 1.0× 111 0.6× 140 1.4× 116 1.5× 32 0.5× 65 844
Deborah Kees‐Folts United States 10 224 1.0× 174 1.0× 75 0.8× 31 0.4× 21 0.3× 16 624
Harald Althaus Germany 13 547 2.5× 151 0.8× 154 1.6× 89 1.2× 20 0.3× 20 1.0k
Ángel Sevillano Spain 18 391 1.8× 187 1.1× 127 1.3× 91 1.2× 12 0.2× 48 883
Kyoung Sook Park South Korea 15 292 1.3× 53 0.3× 87 0.9× 81 1.1× 23 0.3× 24 581
Ioannis Petrakis Greece 13 231 1.0× 126 0.7× 87 0.9× 25 0.3× 13 0.2× 43 506
Pazit Beckerman Israel 11 450 2.0× 270 1.5× 45 0.5× 29 0.4× 21 0.3× 34 770
Yunhua Liao China 15 324 1.5× 68 0.4× 130 1.3× 28 0.4× 37 0.5× 35 835

Countries citing papers authored by Mark Jesky

Since Specialization
Citations

This map shows the geographic impact of Mark Jesky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jesky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jesky more than expected).

Fields of papers citing papers by Mark Jesky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Jesky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jesky. The network helps show where Mark Jesky may publish in the future.

Co-authorship network of co-authors of Mark Jesky

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Jesky. A scholar is included among the top collaborators of Mark Jesky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Jesky. Mark Jesky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCulloch, Thomas A., et al.. (2020). Collapsing Glomerulopathy Affecting Native and Transplant Kidneys in Individuals with COVID-19. ˜The œNephron journals/Nephron journals. 144(11). 589–594. 25 indexed citations
2.
Hutchison, Colin A., Paul Cockwell, V. V. Moroz, et al.. (2019). High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial. The Lancet Haematology. 6(4). e217–e228. 67 indexed citations
3.
Genovese, Federica, Daniel Guldager Kring Rasmussen, M.A. Karsdal, et al.. (2019). Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients. Clinical Kidney Journal. 14(2). 593–601. 23 indexed citations
4.
Beltrami, Cristina, Kate Simpson, Mark Jesky, et al.. (2018). Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease. American Journal Of Pathology. 188(9). 1982–1992. 66 indexed citations
5.
Faustini, Sian, Charlotte N. Cook, Andrew McClean, et al.. (2018). Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease. PLoS ONE. 13(4). e0195730–e0195730. 3 indexed citations
6.
Fenton, Anthony, Mark Jesky, Rachel Webster, et al.. (2018). Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease. PLoS ONE. 13(5). e0197043–e0197043. 6 indexed citations
7.
Nielsen, Signe Holm, Daniel Guldager Kring Rasmussen, Susanne Brix, et al.. (2018). A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease. PLoS ONE. 13(10). e0204239–e0204239. 16 indexed citations
8.
Bentall, Andrew, et al.. (2017). Early eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah’s Witness refusing blood products. Oxford Medical Case Reports. 2017(6). omx025–omx025. 1 indexed citations
9.
Rasmussen, Daniel Guldager Kring, Anthony Fenton, Mark Jesky, et al.. (2017). Urinary endotrophin predicts disease progression in patients with chronic kidney disease. Scientific Reports. 7(1). 17328–17328. 53 indexed citations
10.
Fenton, Anthony, Mark Jesky, Charles J. Ferro, et al.. (2017). Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease. PLoS ONE. 12(4). e0175200–e0175200. 58 indexed citations
11.
Jesky, Mark, Mary Ann Dutton, Indranil Dasgupta, et al.. (2016). Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study. PLoS ONE. 11(11). e0165675–e0165675. 53 indexed citations
12.
Chand, Sourabh, Nicola C. Edwards, Colin D. Chue, et al.. (2015). Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease. Nephrology Dialysis Transplantation. 31(7). 1140–1144. 10 indexed citations
13.
Jesky, Mark, Manvir Hayer, Mark Thomas, & Indranil Dasgupta. (2015). Do Obese Individuals With Hypertension Have More Difficult‐to‐Control Blood Pressure and End Organ Damage Than Their Nonobese Counterparts?. Journal of Clinical Hypertension. 17(6). 466–472. 7 indexed citations
14.
Ng, Khai Ping, Stephanie Stringer, Mark Jesky, et al.. (2014). Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study. PLoS ONE. 9(3). e91961–e91961. 23 indexed citations
15.
Hutchison, Colin A., Stephen J. Harding, Kolitha Basnayake, et al.. (2014). Serum Polyclonal Immunoglobulin Free Light Chain Levels Predict Mortality in People With Chronic Kidney Disease. Mayo Clinic Proceedings. 89(5). 615–622. 39 indexed citations
16.
Sharma, Praveen, Thomas Dietrich, Stephanie Stringer, et al.. (2014). The periodontal health component of the Renal Impairment In Secondary Care (RIISC) cohort study: a description of the rationale, methodology and initial baseline results. Journal Of Clinical Periodontology. 41(7). 653–661. 29 indexed citations
17.
18.
Stringer, Stephanie, Praveen Sharma, Mary Ann Dutton, et al.. (2013). The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrology. 14(1). 95–95. 34 indexed citations
19.
Assi, Lakhvir K., Mark Jesky, Stephanie Stringer, et al.. (2013). A simple scoring algorithm using serum free light chains for the risk assessment of progression of chronic kidney disease. 4. 1 indexed citations
20.
Kubal, Chandrashekhar A., Paul Cockwell, Bridget Gunson, et al.. (2012). Chronic Kidney Disease After Nonrenal Solid Organ Transplantation. Transplantation. 93(4). 406–411. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shikha Wadhwani Breakdown of academic impact, for papers by Umut Selda Bayrakçı Breakdown of academic impact, for papers by Xiaojiang Zhan Breakdown of academic impact, for papers by Deborah Kees‐Folts Breakdown of academic impact, for papers by Harald Althaus Breakdown of academic impact, for papers by Ángel Sevillano Breakdown of academic impact, for papers by Kyoung Sook Park Breakdown of academic impact, for papers by Ioannis Petrakis Breakdown of academic impact, for papers by Pazit Beckerman Breakdown of academic impact, for papers by Yunhua Liao
Rankless by CCL
2026